(SHC) Sotera Health - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US83601L1026

SHC: Sterilization Services, Lab Testing, Advisory Services

Sotera Health Company is a leading provider of comprehensive services that cater to various industries, including medical devices, pharmaceuticals, and food safety, among others. The company's operations are divided into three primary segments: Sterigenics, Nordion, and Nelson Labs, each offering specialized services that are critical to the development and production of safe and effective products. Through its Sterigenics segment, Sotera Health provides sterilization services using gamma and electron beam irradiation, as well as ethylene oxide processing, ensuring that products are free from contaminants and meet stringent regulatory standards.

The company's expertise extends to the design, installation, and maintenance of gamma irradiation systems, which are used to sterilize a wide range of products, from medical devices to food and agricultural products. Additionally, Sotera Health's Nordion segment provides microbiological and analytical chemistry testing services, which are essential for ensuring the quality and safety of products. The company's Nelson Labs segment offers technical assistance, regulatory consulting, and advisory services, helping clients navigate complex regulatory requirements and bringing their products to market efficiently.

Sotera Health's services are highly specialized and play a critical role in various industries, including cancer treatment, high-performance materials, and commercial, advanced, and specialty applications. With a strong global presence, the company serves clients in the United States and internationally, providing them with mission-critical services that are essential to their operations. Founded in 2015 and headquartered in Broadview Heights, Ohio, Sotera Health has established itself as a trusted partner for companies seeking to ensure the quality, safety, and efficacy of their products.

As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol SHC, Sotera Health is committed to delivering value to its shareholders while maintaining the highest standards of quality and service. With a web presence at https://soterahealth.com, the company provides easy access to information about its services, operations, and financial performance. As a common stock with the ISIN US83601L1026, Sotera Health is classified under the GICS Sub Industry: Life Sciences Tools & Services, reflecting its focus on providing specialized services that support the development and production of life sciences products.

Additional Sources for SHC Stock

SHC Stock Overview

Market Cap in USD 3,827m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 2020-11-20

SHC Stock Ratings

Growth 5y -59.1%
Fundamental 37.6%
Dividend -
Rel. Strength Industry -475
Analysts 3.89/5
Fair Price Momentum 11.12 USD
Fair Price DCF 6.53 USD

SHC Dividends

No Dividends Paid

SHC Growth Ratios

Growth Correlation 3m -65.3%
Growth Correlation 12m 20%
Growth Correlation 5y -80.8%
CAGR 5y -14.13%
CAGR/Mean DD 5y -0.37
Sharpe Ratio 12m -0.27
Alpha -52.29
Beta 1.61
Volatility 40.76%
Current Volume 876.1k
Average Volume 20d 982.1k
What is the price of SHC stocks?
As of January 22, 2025, the stock is trading at USD 13.31 with a total of 876,059 shares traded.
Over the past week, the price has changed by +4.31%, over one month by -0.15%, over three months by -14.79% and over the past year by -12.55%.
Is Sotera Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Sotera Health (NASDAQ:SHC) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SHC as of January 2025 is 11.12. This means that SHC is currently overvalued and has a potential downside of -16.45%.
Is SHC a buy, sell or hold?
Sotera Health has received a consensus analysts rating of 3.89. Therefor, it is recommend to buy SHC.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SHC stock price target?
According to ValueRays Forecast Model, SHC Sotera Health will be worth about 12.2 in January 2026. The stock is currently trading at 13.31. This means that the stock has a potential downside of -8.11%.
Issuer Forecast Upside
Wallstreet Target Price 16.2 21.6%
Analysts Target Price 20 50.3%
ValueRay Target Price 12.2 -8.1%